Anti-Human FGF23 Therapeutic Antibody (Burosumab)
Recombinant monoclonal antibody to FGF23. Burosumab is a human monoclonal antibody that can be potentially used in the treatment of Dermatological genetic disorders, Hypophosphatemia, Tumor Induced Osteomalacia (TIO), Epidermal Nevus Syndrome (ENS), X-linked (Hereditary hypophosphatemic rickets), Osteomalacia, oncogenic.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-010ML |
| Pricing | Inquiry |
| Host | Human |
| Target | FGF23 |
| Species Reactivity | Human |
| Type | IgG1, κ |
| Applications | ELISA, IHC, FC, IP, IF, Inhib, PK, FuncS |
| Storage | Store at -20°C for long-term storage. Avoid freeze/thaw cycles. |